Secreted phospholipase A2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures

J Neurosci Res. 2002 Mar 1;67(5):634-45. doi: 10.1002/jnr.10131.

Abstract

Secreted phospholipases A2 (sPLA2s) modulate neuronal survival and neurotransmitter release. Here we show that sPLA2 (group III) synergistically increases glutamate-induced cell death and intracellular calcium ([Ca2+]i) in cultured primary cortical and hippocampal neurons. Whereas 1 microM glutamate elicited transient [Ca2+]i increases in all neurons that recovered 66% to baseline, 25 ng/ml sPLA2 pretreatment resulted in sustained [Ca2+]i increases, with only 5% recovery. At 250 nM glutamate, 25% of neurons failed to respond, and the average recovery time was 101 +/- 12 sec; sPLA2 increased recovery time to 158 +/- 6 sec, and only 2% of cells failed to respond. Both the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 and the calcium-channel blocker cobalt inhibited this effect. Experiments with the glutamate uptake inhibitor L-trans-pyrollidine-2,4-dicarboxylic acid (2.5 microM) indicated that glutamate uptake sites are not a likely modulation point by sPLA2, whereas arachidonic acid (AA) potentiated calcium responses to glutamate. Thus the enhancement of glutamate-induced [Ca2+]i increases by sPLA2 may be due to modulation at NMDA receptors and/or calcium channels by AA. These results indicate that sPLA2 affects neuronal responses to both nontoxic (0.1-10 microM) and toxic (=25 microM) concentrations of glutamate, implicating this enzyme in neuronal functions in pathology.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antimutagenic Agents / pharmacology
  • Arachidonic Acid / pharmacology
  • Calcium / metabolism*
  • Calcium Channels / drug effects
  • Calcium Channels / metabolism
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology*
  • Cell Death / drug effects
  • Cell Death / physiology*
  • Cells, Cultured
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Cobalt / pharmacology
  • Dicarboxylic Acids / pharmacology
  • Dose-Response Relationship, Drug
  • Excitatory Amino Acid Antagonists / pharmacology
  • Glutamic Acid / metabolism*
  • Glutamic Acid / pharmacology
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Intracellular Fluid / drug effects
  • Intracellular Fluid / metabolism
  • Neurons / drug effects
  • Neurons / enzymology*
  • Neurotransmitter Uptake Inhibitors / pharmacology
  • Phospholipases A / metabolism*
  • Phospholipases A / pharmacology
  • Phospholipases A2
  • Pyrrolidines / pharmacology
  • Rats
  • Receptors, N-Methyl-D-Aspartate / drug effects
  • Receptors, N-Methyl-D-Aspartate / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Antimutagenic Agents
  • Calcium Channels
  • Dicarboxylic Acids
  • Excitatory Amino Acid Antagonists
  • Neurotransmitter Uptake Inhibitors
  • Pyrrolidines
  • Receptors, N-Methyl-D-Aspartate
  • Arachidonic Acid
  • Cobalt
  • Glutamic Acid
  • pyrrolidine-2,4-dicarboxylic acid
  • Phospholipases A
  • Phospholipases A2
  • cobaltous chloride
  • Calcium